Lisa Drew
Impact in
- Oncology top 2%
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
-
- Lung Cancer Treatments and Mutations
Papers in
-
- Cell death mechanisms and regulation 7
- Ubiquitin and proteasome pathways 5
- Melanoma and MAPK Pathways 5
- Protein Degradation and Inhibitors 5
- Oncology 26
- Cancer-related Molecular Pathways 14
- Co-authors
- Jamal Saeh (5 shared papers)Nicholas A. Jessop (1 shared paper)Jeffrey A. Engelman (2 shared papers)Balázs Halmos (1 shared paper)John C. Wain (1 shared paper)Lecia V. Sequist (1 shared paper)A. John Iafrate (1 shared paper)Tahsin Khan (1 shared paper)
- Journals
- Cancer Research (10 papers)Blood (8 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Nature Communications (1 paper)Blood Advances (1 paper)
- Partner nations
- United StatesUnited KingdomBrazil
In The Last Decade
Lisa Drew
54 papers receiving 2.2k citations
Lisa Drew's Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 1.0k
- Pulmonary and Respiratory Medicine 849
- Cancer Research 269
- Molecular Biology 1.3k
- Pathology and Forensic Medicine 253
Countries citing papers authored by Lisa Drew
This map shows the geographic impact of Lisa Drew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Drew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Drew more than expected).
Fields of papers citing papers by Lisa Drew
This network shows the impact of papers produced by Lisa Drew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Drew. The network helps show where Lisa Drew may publish in the future.
Co-authors
The 25 scholars most cited alongside Lisa Drew, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers Hit paper breakdown → | 2012 | 984 |
| 2 | 2008 | 407 | |
| 3 | 2020 | 87 | |
| 4 | 2001 | 80 | |
| 5 | 2003 | 65 | |
| 6 | 2019 | 53 | |
| 7 | 2019 | 40 | |
| 8 | 2011 | 39 | |
| 9 | Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143. | 2003 | 37 |
| 10 | 2018 | 36 | |
| 11 | The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells. | 2002 | 32 |
| 12 | 1998 | 27 | |
| 13 | 2022 | 24 | |
| 14 | 2019 | 22 | |
| 15 | 2020 | 19 | |
| 16 | 2008 | 19 | |
| 17 | 1999 | 19 | |
| 18 | 2013 | 18 | |
| 19 | National Survey of Drinking and Driving Attitudes and Behaviors: 2008. Volume I - Summary Report | 2010 | 18 |
| 20 | 1998 | 17 |
About Lisa Drew
Lisa Drew is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Hematology, having authored 55 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (14 papers), Cell death mechanisms and regulation (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Ubiquitin and proteasome pathways (5 papers), Melanoma and MAPK Pathways (5 papers), Protein Degradation and Inhibitors (5 papers) and Acute Myeloid Leukemia Research (5 papers). The work is most often cited by research in Oncology (1.0k citations), Pulmonary and Respiratory Medicine (849 citations), Cancer Research (269 citations), Molecular Biology (1.3k citations) and Pathology and Forensic Medicine (253 citations). Lisa Drew has collaborated with scholars based in United States, United Kingdom and Brazil. Frequent co-authors include Jamal Saeh, Nicholas A. Jessop, Jeffrey A. Engelman, Balázs Halmos, John C. Wain, Lecia V. Sequist, A. John Iafrate, Tahsin Khan, Benjamin Solomon and Alice T. Shaw. Their work appears in journals such as Cancer Research, Blood, Bioorganic & Medicinal Chemistry Letters, Nature Communications and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.